| ²é¿´: 1638 | »Ø¸´: 11 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
ǧÀÖÒø³æ (ÕýʽдÊÖ)
|
[½»Á÷]
´ÓÄÄÀï¿ÉÒԲ鵽ijҩAÊÇ·ñΪP-gpµÄµ×Î
|
|||
|
ÈçÌ⣬´ÓÄÄÀï¿ÉÒԲ鵽ijҩAÊÇ·ñΪP-gpµÄµ×Î ÕâÊÇ¿ÉÒÔÖ±½Ó²éµ½µÄ»¹ÊÇÖ»ÄÜͨ¹ýתÔËϸ°ûʵÑé×Ô¼º·¢ÏÖ£¿ ºÜ¶àÒ©¶¼ÊÇP-gpµÄµ×Îï¡£ÏëÒªÖªµÀijҩÊÇ·ñҲΪP-gpµÄµ×ÎÄÜͨ¹ýÎÄÏ×»òÕßÖ¸ÄÏÖ®ÀàµÄ²éµ½Â𣿴ÓÄĶù²é£¿Ð»Ð»~ [ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¾µä×ÊÔ´Ìû |
» ²ÂÄãϲ»¶
ÉúÎïѧѧ˶Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£©
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÎäÀí085500»úеרҵ×Ü·Ö300Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´
281Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0805 316Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085601Çóµ÷¼Á×Ü·Ö293Ó¢Ò»Êý¶þ
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ17È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çó¡¶°²È«ÑªÒººÍÑªÒºÖÆÆ·¡·Ô±¾»òÏà¹ØÌâ¿â
ÒѾÓÐ4È˻ظ´

°¢Q~~
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 77 (³õÖÐÉú)
- ½ð±Ò: 33343.6
- ºì»¨: 107
- Ìû×Ó: 36186
- ÔÚÏß: 1028.1Сʱ
- ³æºÅ: 3237212
- ×¢²á: 2014-05-27
- ÐÔ±ð: MM
- רҵ: ÓîÖæÑ§

9Â¥2014-11-22 09:14:03
|
^_^ [ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ] |
4Â¥2014-11-19 00:10:27
ǧÀÖ
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 9 (Ó×¶ùÔ°)
- ½ð±Ò: 361.9
- É¢½ð: 70
- ºì»¨: 3
- Ìû×Ó: 429
- ÔÚÏß: 44.2Сʱ
- ³æºÅ: 3163798
- ×¢²á: 2014-04-25
- ÐÔ±ð: MM
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§

5Â¥2014-11-19 00:11:35
ZZCQQ
ľ³æ (ÕýʽдÊÖ)
ÔçÆðßÕ³æÔÒÓÐÄñ³Ô(¡Ño¡Ñ)
- Ó¦Öú: 23 (СѧÉú)
- ½ð±Ò: 5409.9
- É¢½ð: 35
- ºì»¨: 18
- Ìû×Ó: 774
- ÔÚÏß: 160.2Сʱ
- ³æºÅ: 2711597
- ×¢²á: 2013-10-10
- ÐÔ±ð: MM
- רҵ: ÖÐÒ©Ò©´ú¶¯Á¦Ñ§
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ǧÀÖ: ½ð±Ò+5, лл´óÏÀÀ²~ 2014-11-30 15:47:18
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ǧÀÖ: ½ð±Ò+5, лл´óÏÀÀ²~ 2014-11-30 15:47:18
|
P-GPµÄµ×Îï´ó¶¼ÊÇCATIONIC HYDROPHOBIC µÄ»¯ºÏÎï¡£ ÍÆ¼ö¼¸¸ö£º A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.Penzotti JE, Lamb ML, Evensen E, Grootenhuis PD. P-glycoprotein (P-gp) functions as a drug efflux pump, mediating multidrug resistance and limiting the efficacy of many drugs. Clearly, identification of potential P-gp substrate liability early in the drug discovery process would be advantageous. We describe a multiple-pharmacophore model that can discriminate between substrates and nonsubstrates of P-gp with an accuracy of 63%. The application of this filter allows large virtual libraries to be screened efficiently for compounds less likely to be transported by P-gp. PMID: 11960484 [PubMed - indexed for MEDLINE] A general pattern for substrate recognition by P-glycoprotein.Seelig A. Department of Biophysical Chemistry, Biocenter of the University of Basel, Switzerland. seeliga@ubaclu.unibas.ch P-glycoprotein actively transports a wide variety of chemically diverse compounds out of the cell. Based on a comparison of a hundred compounds previously tested as P-glycoprotein substrates, we suggest that a set of well-defined structural elements is required for an interaction with P-glycoprotein. The recognition elements are formed by two (type I unit) or three electron donor groups (type II unit) with a fixed spatial separation. Type I units consist of two electron donor groups with a spatial separation of 2.5 +/- 0.3 A. Type II units contain either two electron donor groups with a spatial separation of 4.6 +/- 0.6 A or three electron donor groups with a spatial separation of the outer two groups of 4.6 +/- 0.6 A. All molecules that contain at least one type I or one type II unit are predicted to be P-glycoprotein substrates. The binding to P-glycoprotein increases with the strength and the number of electron donor or hydrogen bonding acceptor groups forming the type I and type II units. Correspondingly, a high percentage of amino acids with hydrogen bonding donor side chains is found in the transmembrane sequences of P-glycoprotein relevant for substrate interaction. Molecules that minimally contain one type II unit are predicted to be inducers of P-glycoprotein over-expression. PMID: 9492291 [PubMed - indexed for MEDLINE] |

6Â¥2014-11-19 09:32:12













»Ø¸´´ËÂ¥
